Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$6.33 $0.75 (13.44%) RKDA stock closing price Aug 17, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Arcadia Biosciences, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Arcadia Biosciences stock analysis. A company releases its balance sheet every year along with its annual results. The balance sheet shows total liabilities of $8.56M and shareholders equity of $8M. Arcadia Biosciences revenue and Arcadia Biosciences operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Arcadia Biosciences financial performance.
show more
Fiscal year is Jan - Dec20172016201520142013
Cash9.12M2.01M23.97M16.57M2.83M
Marketable Securities3.89M48.54M26.27M--
Receivables1.23M--1.42M1.02M
Inventory-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets-----
Total Current Assets
15.04M52.22M52.01M18.69M4.56M
Property Plant & Equipment5.18M5.44M5.24M5.38M5.27M
Accumulated Depreciation4.88M4.94M4.65M4.65M4.33M
Net Property Plant & Equipment
-----
Investment & Advances-2.49M19.74M-1.43M
Other Non-Current Assets1.16M1.32M1.86M2.14M2.53M
Deferred Charges-----
Intangibles-----
Deposits & Other Assets---2.81M-
Total Assets
16.57M56.57M74.24M24.88M9.54M
Notes Payable---5.6M4.56M
Accounts Payable2.49M2.35M2.42M3.19M2.51M
Current Portion Long-Term Debt-----
Current Portion Capital Leases-----
Accrued Expenses-----
Income Taxes Payable-----
Other Current Liabilities1.02M-1.02M2.46M2.46M
Total Current Liabilities
3.52M3.12M3.45M11.26M9.54M
Mortgages-----
Deferred Taxes/Income2.03M3.12M2.63M3.63M4.37M
Convertible Debt-----
Long-Term Debt-25.12M24.93M8.86M9.92M
Non-Current Capital Leases-----
Other Long-Term Liabilities3M3M3M3M3M
Total Liabilities
8.56M34.37M34.01M26.77M26.83M
Minority Interest-----
Preferred Stock---82.88M-
Common Stock Net-----
Capital Surplus175.22M173.72M172.22M29.2M78.33M
Retained Earnings-167.25M-151.55M-131.92M-113.97M-95.63M
Treasury Stock-----
Other Liabilities--0.01M-0.11M--
Shareholders Equity8M22.19M40.22M-1.88M-17.29M
Total Liabilities & Shareholders Equity16.57M56.57M74.24M24.88M9.54M
All figures in USD. M: Millions of USD, B: Billions of USD.

Most investors just check the Arcadia Biosciences stock price, and Arcadia Biosciences historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Arcadia Biosciences PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: RKDA total assets, which was at $16.57M for 2017 is a balance sheet item representing value of what Arcadia Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. RKDA stock had total liabilities of $8.56M for the year 2017.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
10.26
Debt to equity ratio
0
Asset turnover ratio
0.07
Receivables turnover
5.75
Price to book ratio
2.48